The role of TIM-3 in sepsis: a promising target for immunotherapy?

被引:5
作者
Wang, Changli [1 ]
Liu, Jinhai [1 ]
Wu, Qi [1 ]
Wang, Zhi [1 ]
Hu, Baoji [2 ]
Bo, Lulong [1 ]
机构
[1] Naval Med Univ, Changhai Hosp, Fac Anesthesiol, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Pudong Hosp, Dept Anesthesiol, Pudong Med Ctr, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
TIM-3; Sepsis; immunotherapy; inflammatory response; therapeutic target; T-CELL IMMUNOGLOBULIN; SIGNALING PATHWAY; RECEPTOR TIM-3; RESPONSES; INFLAMMATION; ACTIVATION; SEVERITY; BLOCKADE; LAG-3; IG;
D O I
10.3389/fimmu.2024.1328667
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sepsis remains a significant cause of mortality and morbidity worldwide, with limited effective treatment options. The T-cell immunoglobulin and mucin domain-containing molecule 3 (TIM-3) has emerged as a potential therapeutic target in various immune-related disorders. This narrative review aims to explore the role of TIM-3 in sepsis and evaluate its potential as a promising target for immunotherapy. We discuss the dynamic expression patterns of TIM-3 during sepsis and its involvement in regulating immune responses. Furthermore, we examine the preclinical studies investigating the regulation of TIM-3 signaling pathways in septic models, highlighting the potential therapeutic benefits and challenges associated with targeting TIM-3. Overall, this review emphasizes the importance of TIM-3 in sepsis pathogenesis and underscores the promising prospects of TIM-3-based immunotherapy as a potential strategy to combat this life-threatening condition.
引用
收藏
页数:10
相关论文
共 76 条
[1]   Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells [J].
Anderson, Ana C. ;
Anderson, David E. ;
Bregoli, Lisa ;
Hastings, William D. ;
Kassam, Nasim ;
Lei, Charles ;
Chandwaskar, Rucha ;
Karman, Jozsef ;
Su, Ee W. ;
Hirashima, Mitsuomi ;
Bruce, Jeffrey N. ;
Kane, Lawrence P. ;
Kuchroo, Vijay K. ;
Hafler, David A. .
SCIENCE, 2007, 318 (5853) :1141-1143
[2]   Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation [J].
Anderson, Ana C. ;
Joller, Nicole ;
Kuchroo, Vijay K. .
IMMUNITY, 2016, 44 (05) :989-1004
[3]   Tim-3 co-stimulation promotes short-lived effector T cells, restricts memory precursors, and is dispensable for T cell exhaustion [J].
Avery, Lyndsay ;
Filderman, Jessica ;
Szymczak-Workman, Andrea L. ;
Kane, Lawrence P. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (10) :2455-2460
[4]   Endotoxin tolerance: new mechanisms, molecules and clinical significance [J].
Biswas, Subhra K. ;
Lopez-Collazo, Eduardo .
TRENDS IN IMMUNOLOGY, 2009, 30 (10) :475-487
[5]   Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study [J].
Blanco, Jesus ;
Muriel-Bombin, Arturo ;
Sagredo, Victor ;
Taboada, Francisco ;
Gandia, Francisco ;
Tamayo, Luis ;
Collado, Javier ;
Garcia-Labattut, Angel ;
Carriedo, Demetrio ;
Valledor, Manuel ;
De Frutos, Martin ;
Lopez, Maria-Jesus ;
Caballero, Ana ;
Guerra, Jose ;
Alvarez, Braulio ;
Mayo, Agustin ;
Villar, Jesus .
CRITICAL CARE, 2008, 12 (06)
[6]   A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis [J].
Boomer, Jonathan S. ;
Shuherk-Shaffer, Jennifer ;
Hotchkiss, Richard S. ;
Green, Jonathan M. .
CRITICAL CARE, 2012, 16 (03)
[7]   A network-based analysis of systemic inflammation in humans [J].
Calvano, SE ;
Xiao, WZ ;
Richards, DR ;
Felciano, RM ;
Baker, HV ;
Cho, RJ ;
Chen, RO ;
Brownstein, BH ;
Cobb, JP ;
Tschoeke, SK ;
Miller-Graziano, C ;
Moldawer, LL ;
Mindrinos, MN ;
Davis, RW ;
Tompkins, RG ;
Lowry, SF .
NATURE, 2005, 437 (7061) :1032-1037
[8]   T-cell immunoglobulin and mucin-domain containing-3 (TIM-3): Solving a key puzzle in autoimmune diseases [J].
Chen, Huihui ;
Zha, Jie ;
Tang, Runyan ;
Chen, Guochun .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 121
[9]   Clinical significance of serum soluble T-cell immunoglobulin and mucin domain 3 levels in systemic sclerosis: Association with disease severity [J].
Chiba, Miki ;
Yanaba, Koichi ;
Hayashi, Mitsuha ;
Yoshihara, Yuki ;
Nakagawa, Hidemi .
JOURNAL OF DERMATOLOGY, 2017, 44 (02) :194-197
[10]   Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 [J].
Chiba, Shigeki ;
Baghdadi, Muhammad ;
Akiba, Hisaya ;
Yoshiyama, Hironori ;
Kinoshita, Ichiro ;
Dosaka-Akita, Hirotoshi ;
Fujioka, Yoichiro ;
Ohba, Yusuke ;
Gorman, Jacob V. ;
Colgan, John D. ;
Hirashima, Mitsuomi ;
Uede, Toshimitsu ;
Takaoka, Akinori ;
Yagita, Hideo ;
Jinushi, Masahisa .
NATURE IMMUNOLOGY, 2012, 13 (09) :832-842